The George Washington University Biostatistics Center
28
5
5
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
21.4%
6 terminated/withdrawn out of 28 trials
73.9%
-12.6% vs industry average
64%
18 trials in Phase 3/4
88%
15 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Role: lead
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
Role: lead
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
Role: lead
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
Role: lead
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Role: collaborator
Pravastatin to Prevent Preeclampsia
Role: lead
Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT
Role: collaborator
Prenatal Genetic Diagnosis by Genomic Sequencing
Role: collaborator
Cord Clamping Among Neonates With Congenital Heart Disease
Role: collaborator
An Observational Study of Hepatitis C Virus in Pregnancy
Role: lead
Opioid Prescription After Cesarean Trial
Role: lead
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
Role: lead
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Role: lead
Maternal Morbidity and Mortality During the COVID-19 Pandemic
Role: lead
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
Role: lead
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Role: lead
Repeat Antenatal Steroids Trial
Role: lead
Fetal Pulse Oximetry Trial (FOX)
Role: lead
Management of Myelomeningocele Study (MOMS)
Role: lead
Fetal ST Segment and T Wave Analysis in Labor
Role: lead